Strides Arcolab Receives FDA Approval to Market Product

by Kathy Jones on  April 14, 2011 at 8:08 PM Corporate News
RSS Email Print This Page Comment
One of India's leading drug manufacturers, Strides Arcolab has revealed that it has received approval from the US Food and Drug Administrator to market its first liquid injection sterile product that is currently being manufacturer at its new facility in Bangalore.
 Strides Arcolab Receives FDA Approval to Market Product
Strides Arcolab Receives FDA Approval to Market Product

The company confirmed through a press statement that it has received the permission to commercially market the product but added that it was unable to disclose the name of the product due to a confidentiality agreement.

Confirming the statement, the CEO of Agila Specialties, a wholly-owned specialities division of Strides Arcolab, Venkat Iyer said, "The USFDA approval for the product from the new site will go a long way in ameliorating product shortages in the critical therapeutic areas. Two significant product approvals from the new facility augur well for the launch of a series of products in the USA during 2011."

Share prices of Strides Arcolab shot up to an intra-day high of Rs 397.85 before settling down to Rs 388.50, up by 1.16 per cent, on the Bombay Stock Exchange.


Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive